Pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with docetaxel-pretreated, metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort E.
Resource Type
Article
Authors
Augustin, Marinela ; Laguerre, Brigitte ; Baldini, Capucine ; Zedan, Ahmed H. ; Gonzalez-Billalabeitia, Enrique ; Fong, Peter C.C. ; Zukov, Ruslan ; Hammerer, Peter ; Prentice, Mark ; Shore, Neal D. ; Necchi, Andrea ; Todenhöfer, Tilman ; Kessler, Elizabeth R. ; Köse, Fatih ; Gurney, Howard ; Perez Valderrama, Begona ; Zhu, Pengfei ; Imai, Kentaro ; liu, yingjie ; McDermott, Raymond S.
Source
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p148-148, 235p
Subject
Language
ISSN
0732183X